Capital Fund Management S.A. Sarepta Therapeutics, Inc. Put Options Transaction History

Capital Fund Management S.A.

3 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q4 2018 Feb 13, 2019	SELL	$97.32 - $148.76 $1.82 Million - $2.78 Million	-18,700 Reduced 57.36%	13,900 $1.52 Million
Q3 2018 Nov 14, 2018	BUY	$115.31 - $161.51 $2.84 Million - $3.97 Million	24,600 Added 307.5%	32,600 $5.27 Million
Q2 2018 Aug 14, 2018	BUY	$71.74 - $153.69 $573,920 - $1.23 Million	8,000 New	8,000 $1.06 Million

529

84.2M

2.06M

1.52M

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $10.4B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

Get notified when there are updates to the investment portfolio of Capital Fund Management S.A., based on Form 13F filings with the SEC.

Stay updated on Capital Fund Management S.A. with notifications on news.